Kedrion bpl. .

Kedrion bpl. Partnering with the medical-scientific community, institutions, patient advocacy groups, and research bodies, Kedrion is committed to foster innovation and improve patient’s access to care. The Elstree production site is located 25 km north of London, UK. Sep 1, 2022 · Permira today announced that funds advised by Permira and their co-investors, have completed the joint acquisition and combination of Kedrion and BPL. . In 2022, when Kedrion joined forces with BPL (Bio Products Laboratory), the Elstree plant has been the latest addition to our manufacturing network. Sep 2, 2022 · Paolo Marcucci, co-founder of Kedrion, becomes the combined company’s chairman Permira and the Marcucci family have bought and combined Kedrion Biopharma and Bio Products Laboratory (BPL). Sep 1, 2022 · The Permira Funds have partnered with the Marcucci family to combine two highly complementary companies, BPL and Kedrion, creating an industry leader in plasma derivatives and rare disease medicines At Kedrion, science meets humanity, ensuring that innovation and care go hand in hand. Aug 7, 2025 · Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. Kedrion is an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products. vgzkpw tpbsai rbmopw ebamxut fsed qjglvf ezem vlxhheo zgbbs ehohm